JNJ · Healthcare
Johnson & Johnson
36/100
Smart-money confidence1 of 3 sources positive
Below average interest
company insiders are selling
What this band has actually done: stocks scoring 0–25 beat the S&P 500 over the next three months 39.9% of the time, across 100,496 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this
Hedge funds
64
Congress
No data
Insiders
0
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
Market cap
$655.4B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NYSE
About JOHNSON & JOHNSON
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of…
Who's behind the signal
Every informed buyer we can see on JNJ, across all three feeds.
Hedge funds · 12
Millennium Management (Englander)
Increased +3%
Tweedy Browne
Decreased −8%
Markel Group (Tom Gayner)
Unchanged
Bridgewater Associates (Dalio)
Decreased −4%
Elliott Investment Mgmt
Unchanged
AQR Capital Management
Decreased −18%
+6 more in the full breakdown below ↓
Congress · 20
Thomas H. Kean, Jr.
sold
John Boozman
sold
Richard McCormick
sold
Lloyd Doggett
bought
Alan Armstrong
bought
Julie Johnson
sold
Lisa C. McClain
sold
Jared Moskowitz
sold
+12 more in the full record below ↓
Insiders
Company insiders
Selling
Recent sells10
Congressional trades · 50 on record
Disclosures from 2025-01-24 to 2026-08-27
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2026-08-27 | Thomas H. Kean, Jr. · R-NJ | House | Sold | $1,001 - $15,000 |
| 2026-08-20 | John Boozman · R-AR | Senate | Sold | $1,001 - $15,000 |
| 2026-07-30 | Richard McCormick · R-GA | House | Sold | $1,001 - $15,000 |
| 2026-06-29 | Thomas H. Kean, Jr. · R-NJ | House | Sold | $1,001 - $15,000 |
| 2026-06-09 | Lloyd Doggett · D-TX | House | Bought | $1,001 - $15,000 |
| 2026-06-02 | Thomas H. Kean, Jr. · R-NJ | House | Sold | $1,001 - $15,000 |
| 2026-03-30 | Alan Armstrong · R-OK | Senate | Bought | $1,001 - $15,000 |
| 2026-03-27 | Alan Armstrong · R-OK | Senate | Bought | $15,001 - $50,000 |
| 2026-03-26 | Thomas H. Kean, Jr. · R-NJ | House | Sold | $1,001 - $15,000 |
| 2026-03-19 | Richard McCormick · R-GA | House | Sold | $1,001 - $15,000 |
Show the other 40
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2026-03-19 | John Boozman · R-AR | Senate | Sold | $1,001 - $15,000 |
| 2026-03-10 | Lloyd Doggett · D-TX | House | Bought | $1,001 - $15,000 |
| 2026-01-23 | Thomas H. Kean, Jr. · R-NJ | House | Sold | $15,001 - $50,000 |
| 2025-12-18 | Julie Johnson · D-TX | House | Sold | $1,001 - $15,000 |
| 2025-12-09 | Lloyd Doggett · D-TX | House | Bought | $1,001 - $15,000 |
| 2025-11-20 | Thomas H. Kean, Jr. · R-NJ | House | Sold | $15,001 - $50,000 |
| 2025-11-13 | Julie Johnson · D-TX | House | Sold | $1,001 - $15,000 |
| 2025-11-05 | Richard McCormick · R-GA | House | Bought | $1,001 - $15,000 |
| 2025-10-31 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-10-30 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-10-30 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2025-10-10 | Jared Moskowitz · D-FL | House | Sold | $1,001 - $15,000 |
| 2025-09-23 | Val T. Hoyle · D-OR | House | Sold | $1,001 - $15,000 |
| 2025-08-19 | Kelly Morrison · D-MN | House | Sold | $1,001 - $15,000 |
| 2025-08-14 | Julie Johnson · D-TX | House | Sold | $1,001 - $15,000 |
| 2025-08-04 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2025-07-31 | Thomas H. Kean, Jr. · R-NJ | House | Sold | $15,001 - $50,000 |
| 2025-06-24 | Lisa C. McClain · R-MI | House | Sold | $1,001 - $15,000 |
| 2025-06-17 | Lisa C. McClain · R-MI | House | Bought | $1,001 - $15,000 |
| 2025-06-16 | Scott Franklin · R-FL | House | Sold | $15,001 - $50,000 |
| 2025-06-12 | Pete Sessions · R-TX | House | Sold | $15,001 - $50,000 |
| 2025-06-10 | Lloyd Doggett · D-TX | House | Bought | $1,001 - $15,000 |
| 2025-05-30 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $15,001 - $50,000 |
| 2025-05-12 | Jefferson Shreve · R-IN | House | Sold | $50,001 - $100,000 |
| 2025-05-05 | Marjorie Taylor Greene · R-GA | House | Bought | $1,001 - $15,000 |
| 2025-04-29 | Gilbert Ray Cisneros, Jr. · D-CA | House | Sold | $1,001 - $15,000 |
| 2025-04-21 | Bruce Westerman · R-AR | House | Sold | $1,001 - $15,000 |
| 2025-04-09 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2025-04-08 | Robert P. Bresnahan, Jr. · R-PA | House | Sold | $1,001 - $15,000 |
| 2025-04-01 | Julie Johnson · D-TX | House | Sold | $1,001 - $15,000 |
| 2025-03-31 | Gilbert Ray Cisneros, Jr. · D-CA | House | Bought | $15,001 - $50,000 |
| 2025-03-24 | George Whitesides · D-CA | House | Sold | $100,001 - $250,000 |
| 2025-03-19 | Sheri Biggs · R-SC | House | Sold | $15,001 - $50,000 |
| 2025-03-07 | Josh Gottheimer · D-NJ | House | Sold | $1,001 - $15,000 |
| 2025-03-05 | Jefferson Shreve · R-IN | House | Bought | $15,001 - $50,000 |
| 2025-03-04 | Lloyd Doggett · D-TX | House | Bought | $1,001 - $15,000 |
| 2025-03-03 | Bruce Westerman · R-AR | House | Bought | $1,001 - $15,000 |
| 2025-02-24 | Jefferson Shreve · R-IN | House | Bought | $15,001 - $50,000 |
| 2025-01-24 | Gilbert Ray Cisneros, Jr. · D-CA | House | Sold | $1,001 - $15,000 |
| 2025-01-24 | Josh Gottheimer · D-NJ | House | Bought | $1,001 - $15,000 |
Not a model pick — but on our radar.
JOHNSON & JOHNSON isn't in the top-10 model right now, but 12 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
12
Investors
0
New positions
1
Increasing
8
Decreasing
3
Unchanged
Price History
Loading price data...
A member of Congress bought
A member sold
Return:
High:
Low:
Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.0×
% of portfolio
0.1%
Position change
+3%
0.1% of Millennium Management's portfolio
Trust weight: 1.2×
% of portfolio
3.9%
Position change
−8%
3.9% of Tweedy Browne's portfolio
Trust weight: 1.4×
% of portfolio
1.2%
Position change
—
1.2% of Markel Group's portfolio
Trust weight: 1.3×
% of portfolio
0.7%
Position change
−4%
0.7% of Bridgewater Associates's portfolio
Trust weight: 1.3×
% of portfolio
0.3%
Position change
—
0.3% of Elliott Investment Mgmt's portfolio
Trust weight: 1.0×
% of portfolio
0.3%
Position change
−18%
0.3% of AQR Capital Management's portfolio
Trust weight: 1.3×
% of portfolio
0.2%
Position change
−4%
0.2% of Polen Capital Management's portfolio
Trust weight: 1.0×
% of portfolio
0.2%
Position change
−22%
0.2% of Citadel Advisors's portfolio
Trust weight: 1.5×
% of portfolio
0.1%
Position change
−2%
0.1% of Soros Fund Management's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
−12%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.0×
% of portfolio
0.1%
Position change
−10%
0.1% of D.E. Shaw & Co's portfolio
Trust weight: 1.2×
% of portfolio
0.0%
Position change
—
0.0% of Dodge & Cox's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to JOHNSON & JOHNSON
Insider Trading (Form 4)
Recent trades by company officers and directors — filed within 2 days of each trade
Bearish
Sentiment
0
Buys
10
Sells
| Date | Insider | Title | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-02 | Schmid Timothy | Insider | SELL | 22,527 | $274.74 | $6,189,068 |
| 2026-09-02 | Schmid Timothy | Insider | SELL | 11,070 | $274.74 | $3,041,372 |
| 2026-08-17 | Taubert Jennifer L | Insider | SELL | 15,000 | $263.36 | $3,950,400 |
| 2026-08-13 | Duato Joaquin | Insider | SELL | 102,315 | $261.00 | $26,704,215 |
| 2026-08-13 | Duato Joaquin | Insider | SELL | 20,976 | $262.00 | $5,495,712 |
| 2026-08-06 | Forminard Elizabeth | Insider | SELL | 6,574 | $255.93 | $1,682,497 |
| 2026-08-06 | Forminard Elizabeth | Insider | SELL | 9,344 | $257.75 | $2,408,463 |
| 2026-08-05 | Duato Joaquin | Insider | SELL | 6,523 | $258.74 | $1,687,754 |
| 2026-08-05 | Duato Joaquin | Insider | SELL | 41,957 | $258.06 | $10,827,256 |
| 2026-07-20 | Broadhurst Vanessa | Insider | SELL | 23,054 | $251.27 | $5,792,686 |
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell JOHNSON & JOHNSON or any security.
Get the Weekly Update
Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime